Tag: Herceptin
![](https://owise.uk/wp-content/uploads/sites/2/2021/04/Diane-Lavin-e1618574801785-746x498.jpeg)
Living with HER2+ Secondary Breast Cancer: Diane Lavin’s Experience
In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.
![](https://owise.uk/wp-content/uploads/sites/2/2021/04/beak-746x498.png)
HER2 Secondary Breast Cancer: All of the treatments explained
In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.
![Untangling drug terminology](https://owise.uk/wp-content/uploads/sites/2/2021/01/ORNGE-2-746x498.png)
Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab
We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).
![Clinical trials - a doctor holding a new drig](https://owise.uk/wp-content/uploads/sites/2/2020/12/clinical-trials-e1606994189655-649x498.png)
Clinical Trials for Breast Cancer: Our A to Z Guide
Want to better understand what clinical trials are and what they mean for you? Here is OWise’s extensive guide to all things clinical trials.
![Scientific image of pipette with pink liquid being placed into plate](https://owise.uk/wp-content/uploads/sites/2/2020/06/louis-reed-pwcKF7L4-no-unsplash-746x498.jpg)
HER2 and Herceptin®: A Look at the History
The discovery of the HER2 gene led to the development of Herceptin®: a targeted therapy that is widely used today for HER2+ breast cancer patients.